FSRH CEU Statement : New advice from the MHRA regarding cyproterone acetate: how does this affect prescribing of Co-cyprindiol/Dianette® for acne/hirsutism? July 2020

86a9c88104476b6c8826a3fae68f65b8

Published on: 13 July 2020

File size: 189kb PDF

File type: Clinical Statements

This statement is a response to new advice from the MHRA regarding use of cyproterone acetate and risk of meningioma.

Your download should start automatically. If not download directly.